Epidemiological and clinical studies over the past decade have firmly established that
elevated plasma concentrations of lipoprotein (a)(Lp (a)) are an important, independent and …

It has been estimated that∼ 37% of the US population judged to be at high risk for
developing coronary artery disease (CAD), based on the National Cholesterol Education …

The initial studies focusing on lipoprotein (a)[Lp (a)] and its role in atherosclerotic
cardiovascular disease were conducted exclusively in Whites. Subsequently, multiple large …

Background: A role of inflammation for cardiovascular disease (CVD) is established.
Lipoprotein (a)[Lp (a)] is an independent CVD risk factor where plasma levels are …

Lipoprotein (a)[Lp (a)] is a highly atherogenic lipid particle. Although earlier reports
suggested that Lp (a) levels are mostly determined by genetic factors, several recent studies …

In 1994, the landmark 4S trial (Scandinavian Simvastatin Survival Study) reported that
lowering low-density lipoprotein (LDL) cholesterol with simvastatin reduced cardiovascular …

Although numerous studies since the 1960s have identified increased plasma
concentrations of lipoprotein (a)[Lp (a)] as a risk factor for coronary heart disease (CHD), the …

Abstract Lipoprotein (a)[Lp (a)] has been recognized for nearly 30 years, and increasingly,
associated with the processes of atherogenesis and thrombogenesis. Despite this, the …

Background Lipoprotein (a)[Lp (a)] is a genetic risk factor for cardiovascular disease (CVD),
and proinflammatory interleukin-1 (IL-1) genotypes may influence Lp (a)-mediated CVD …

Abstract Lipoprotein (a), or Lp (a), is structurally like low‐density lipoprotein (LDL) but differs
in that it contains glycoprotein apolipoprotein (a)[apo (a)]. Due to its prothrombotic and …